Antidiabetics Market | Industry Growth by Forecast to 2025
Date: 2020-03-03   Author: Rahul Varpe  Category: #news

Antidiabetics Market | Industry Growth by Forecast to 2025

Global Antidiabetics Market value is set to achieve a significant CAGR from 2019 to 2025, as per the new research report. With the exponentially growing population and the prevalence of a sedentary lifestyle, a significant rise in the patient pool suffering from diabetes has been observed, which is likely to spur global antidiabetics market share. The WHO estimates that diabetes would be among the leading causes of death by 2030, which would severely strain the overall healthcare fraternity. The rising number of diabetic cases have prompted the governments across various geographies to take steps toward promoting awareness regarding this disorder. For instance, the ‘Diabetes UK’ is slated to launch one of the biggest campaigns to encourage consciousness regarding Type II diabetes. The program will also make people aware of the harmful consequences of developing diabetes, encourage them to get screened regularly, and provide other related details. The prevalence of campaigns and awareness programs such as the aforementioned are certain to bring about a positive influence on antidiabetics market size, which was pegged at USD 49.5 billion in 2016.

Get a Sample Copy of this Report http://decresearch.com/request-sample/detail/504

Inherently propelled by a stringent regulatory framework, Antidiabetics market is strongly characterized by the legalized norms implemented by authorized bodies such as the European CE and the FDA. Having undertaken the crucial responsibility of regulating the commercialization of antidiabetics in clinical trials, these organizations continue to strive hard to approve drugs post their testing with utmost caution and precision, which is a prime factor driving the growth of antidiabetics industry. For instance, recently, the U.S. Food and Drug Administration approved the Bydureon BCise (exenatide extended-release) injectable suspension manufactured by AstraZeneca. Apparently, this drug is an all-new formulation of Bydureon that is available as a single-dose autoinjector device for adults suffering from Type II diabetes. The Bydureon BCise apparently underwent two clinical trials prior to obtaining the approval, thus validating the fact that antidiabetics market outlook is strictly defined by a regulatory frame of reference.

In consequence to the unmet medical requirements of the healthcare fraternity and the rapid increase in the diabetic patient base, antidiabetics industry players have been concentrating on increasing their funding on research & development activities with an aim to launch novel insulin products that will efficiently treat this persistent sugar disorder. Major companies such as Sanofi Aventis, Eli Lilly, and Novo Nordisk presently predominate antidiabetic market share, pertaining to their popular brand value, wide range of products, and increased R&D investments. Many antidiabetics products that are currently in the pipeline to be commercialized are manufactured by these companies. In addition, global antidiabetics industry involves the participation of other generic manufacturers such as Pfizer, Oramed Pharmaceuticals, Inc., Takeda Pharmaceuticals, Boehringer Ingelheim, and Merck & Co. Inc.

Make an Inquiry for Purchasing this Report @ http://decresearch.com/inquiry-before-buying/504

An insight into APAC antidiabetics market trends

The Asia Pacific region has been forecast to emerge as the potential hotbed for investors emptying their coffers in antidiabetics industry. This estimation may be attributed to the fact that the region has been witnessing a tremendous surge in the patient pool suffering from diabetes, especially in India and China. As per reliable statistics, close to nearly two decades earlier, in 2000, India stood at the top of the pyramid representing diabetes sufferers, with more than 31.7 million of its populace afflicted by the disease, while China stood at the second place with 20.8 million diabetic patients in tow. It has been forecast that by 2030, this number would increase up to 79.4 million patients in India and 42.3 million individuals in China. The estimates stand to validate that these countries would prove to be lucrative grounds for companies partaking in antidiabetics market share, as they would be able to bring forth a range of medications for treating the affliction in these regions.

Report Content

Chapter 1.  Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1.  Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2.  Primary

Chapter 2.  Executive Summary

2.1. Antidiabetics industry 3600 synopsis, 2013 – 2024 (USD Million)

2.1.1.  Business trends

2.1.2.  Product trends

2.1.3.  Patient population trends

2.1.4.  Route of administration trends

2.1.5.  Regional trends

Browse Complete Table of Content @ http://decresearch.com/toc/detail/antidiabetics-market

Chapter 3.  Antidiabetics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1.  Strong product pipeline of antidiabetics

3.3.1.2.    Globally rising prevalence of diabetes

3.3.1.3.    Increasing prevalence of lifestyle induced disorders such as obesity

3.3.2.  Industry pitfalls and challenges

3.3.2.1.  Prohibitive cost of insulin

3.4. Regulatory landscape

3.4.1.  U.S.

3.4.2.  Europe

3.5. Clinical workflow analysis

3.6. Reimbursement scenario

3.6.1.  U.S.

3.6.2.  Europe

3.6.3.  Australia

3.7. Growth potential analysis

3.7.1.  By product

3.7.2.  By patient population

3.7.3.  By route of administration

3.8. Porter’s analysis

3.9. Competitive landscape

3.9.1.  Company market share analysis, 2017

3.9.2.  Strategy dashboard

3.10. PESTEL analysis

3.11. Pipeline overview, 2018



About Author


Rahul Varpe

Rahul Varpe

Rahul Varpe currently writes for algosonline. A communication Engineering graduate by education, Rahul started his journey in as a freelancer writer along with regular jobs. Rahul has a prior experience in writing as well as marketing of services and products online. ...

Read More

More from Rahul


Post Recommendents

Hotstar announces availability of Disney+ content for Indian users
Author: Saipriya Iyer

The content from Disney+, a subscription video on-demand streaming service, is officially available on Hotstar, an Indian over-the-top streaming service, after a slight delay.

Var...


Oxygen Cylinders and Concentrators Market Research Report By Current & Future Trends, Statistics To 2025
Author: Rahul Varpe

The Oxygen Cylinders and Concentrators Market is projected to expand from its present industry value of over $2.7 billion to more than $5 billion over the analysis timeframe.


According to the study with title ‘Global Oxygen...


Antidiabetics Market is set to record 10.6% CAGR during forecast time
Author: Rahul Varpe

The size of the Antidiabetics Market was accrued at USD 54.6 billion in 2017 and is presumed to accumulate over USD 110 billion by the year 2024. According to research, the Antidiabetics Market is expected to grow with a CAGR of 10.6% during the p...